HekaBio Welcomes Deron Wolfe as Chief Financial Officer

We are pleased to announce that Deron Wolfe has joined HekaBio K.K. as Chief Financial Officer.

Deron brings nearly three decades of experience in global capital markets, having held senior leadership roles in Corporate Finance, Research, and Equity Sales at UBS and Keefe, Bruyette & Woods (KBW). Most recently, he served as Head of Equity Sales and was a Member of the Executive Committee at KBW.

Throughout his career, Deron has successfully raised capital for financial services and Fintech companies through private placements, IPOs and follow-on offerings. His deep expertise in capital strategy and investor engagement will support HekaBio’s continued growth and our mission to accelerate patient access to world-leading healthcare innovations across Japan and the Asia-Pacific region.

Deron holds a B.A. in Economics from Miami University in Oxford, Ohio, with minors in Decision Sciences and French. He is based in Bronxville, New York.

We are excited to welcome Deron to our leadership team as we enter a pivotal phase of commercialization and portfolio expansion.

Click here for Deron's bio

Click here to connect with Deron on LinkedIn